ALS

QurAlis Announces New Investors to Help Fund Drive to Cure ALS
QurAlis Announces New Investors to Help Fund Drive to Cure ALS
CP Wire
QurAlis
ALS
Flag link:
QurAlis Announces New Investors to Help Fund Drive to Cure ALS
QurAlis
ALS
Flag link:
Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer
Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer
Marketwatch
Sangamo
Pfizer
ALS
gene therapy
drug development
Flag link:
New target could yield treatment for Alzheimer's, ALS and more
New target could yield treatment for Alzheimer's, ALS and more
Fierce Biotech
Genentech
Roche
drug development
R&D
Alzheimer's disease
ALS
Flag link:
The First ALS Drug In 22 Years Is Approved -- And It Costs 4 Times What It Does In Japan
The First ALS Drug In 22 Years Is Approved -- And It Costs 4 Times What It Does In Japan
Forbes
ALS
drug pricing
MT Pharma
Radicava
Flag link:
FDA OKs stem cell-gene therapy trial for ALS
FDA OKs stem cell-gene therapy trial for ALS
Drug Delivery Business
FDA
stem cells
gene therapy
ALS
Flag link:
Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D
Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D
Endpoints
R&D
startups
ALS
Lou Gehrig's disease
Amylyx
Henri Termeer
Flag link:
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
TheStreet.com
BrainStorm Cell Therapeutics
stem cells
clinical trials
ALS
NurOwn
Flag link:
Biogen, Columbia to Map ALS Disease Genes With Ice Bucket Money
Biogen, Columbia to Map ALS Disease Genes With Ice Bucket Money
Bloomberg
Biogen
Columbia University
ALS
social media
Flag link:
How a drug shift set the stage for a potential winner for ALS patients
How a drug shift set the stage for a potential winner for ALS patients
Bizjournals.com
ALS
Lou Gehrig's disease
Tirasemtiv
Cytokinetics
Flag link:
Teva Pharm told to return intellectual property to Proneuron Biotechnologies
Teva Pharm told to return intellectual property to Proneuron Biotechnologies
Yahoo/Reuters
Teva Pharmaceutical
Proneuron Biotechnologies
ALS
Flag link:
What's driving the massive social media campaign for Genervon's ALS drug?
What's driving the massive social media campaign for Genervon's ALS drug?
Fierce Biotech
social media
Genervon
ALS
Lou Gehrig's disease
compassionate use guidelines
Flag link:
The FDA calls on Genervon to release data from controversial ALS study
The FDA calls on Genervon to release data from controversial ALS study
Fierce Biotech
FDA
Genervon
ALS
GM604
Flag link:
Exclusive: Biogen shortens name, expands ambitions in Alzheimer's, ALS
Exclusive: Biogen shortens name, expands ambitions in Alzheimer's, ALS
Yahoo/Reuters
Biogen Idec
ALS
Alzheimer's disease
Flag link:
Neuralstem tanks on cloudy results for its ALS treatment
Neuralstem tanks on cloudy results for its ALS treatment
Fierce Biotech
Neuralstem
ALS
NSI-566
Flag link:
Biogen, academic collaborators discover new ALS gene
Biogen, academic collaborators discover new ALS gene
BioPharma Dive
Biogen Idec
ALS
R&D
Lou Gehrig's disease
Flag link:
Israel's BrainStorm says stem cell drug benefits most patients in ALS trial
Israel's BrainStorm says stem cell drug benefits most patients in ALS trial
Reuters
BrainStorm Cell Therapeutics
stem cells
ALS
Lou Gehrig's disease
NurOwn
Flag link:
Brainstorm Cell Therapeutics Hits One-Year High Today
Brainstorm Cell Therapeutics Hits One-Year High Today
TheStreet.com
BrainStorm Cell Therapeutics
stem cells
NurOwn
ALS
Lou Gehrig's disease
Flag link:
Genervon ALS drug shows encouraging results
Genervon ALS drug shows encouraging results
Seeking Alpha
Genevron
ALS
GM604
Flag link:
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy
TheStreet.com
BrainStorm Cell Therapeutics
ALS
Flag link:

Pages